5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

被引：942

作者：

Cardoso, F. ^{[1
]}

Paluch-Shimon, S. ^{[2
]}

Senkus, E. ^{[3
]}

Curigliano, G. ^{[4
]}

Aapro, M. S. ^{[5
]}

Andre, F. ^{[6
]}

Barrios, C. H. ^{[7
]}

Bergh, J. ^{[8
,9
]}

Bhattacharyya, G. S. ^{[10
]}

Biganzoli, L. ^{[11
]}

Boyle, F. ^{[12
]}

Cardoso, M-J ^{[1
,13
]}

Carey, L. A. ^{[14
]}

Cortes, J. ^{[15
,16
,17
]}

El Saghir, N. S. ^{[18
]}

Elzayat, M. ^{[19
]}

Eniu, A. ^{[20
]}

Fallowfield, L. ^{[21
]}

Francis, P. A. ^{[22
]}

Gelmon, K. ^{[23
]}

Gligorov, J. ^{[24
]}

Haidinger, R. ^{[25
]}

Harbeck, N. ^{[26
]}

Hu, X. ^{[27
]}

Kaufman, B. ^{[28
]}

Kaur, R. ^{[29
]}

Kiely, B. E. ^{[30
]}

Kim, S-B ^{[31
]}

Lin, N. U. ^{[32
]}

Mertz, S. A. ^{[33
]}

Neciosup, S. ^{[34
]}

Offersen, B., V ^{[35
]}

Ohno, S. ^{[36
]}

Pagani, O. ^{[37
]}

Prat, A. ^{[38
,39
,40
]}

Penault-Llorca, F. ^{[41
,42
]}

Rugo, H. S. ^{[43
]}

Sledge, G. W. ^{[44
]}

Thomssen, C. ^{[45
]}

Vorobiof, D. A. ^{[46
]}

Wiseman, T. ^{[47
]}

Xu, B. ^{[48
]}

Norton, L. ^{[49
]}

Costa, A. ^{[50
,51
]}

Winer, E. P. ^{[32
]}

机构：

[1] Champalimaud Fdn, Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal

[2] Hadassah Univ Hosp, Sharett Div Oncol, Jerusalem, Israel

[3] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland

[4] Univ Milan, European Inst Oncol, Dept Oncol & Hematooncol, Div Early Drug Dev,IRCCS, Milan, Italy

[5] Clin Genolier, Breast Ctr, Genolier, Switzerland

[6] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France

[7] Grp Oncoclin, Latin Amer Cooperat Oncol Grp LACOG, Porto Alegre, RS, Brazil

[8] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden

[9] Univ Hosp, Stockholm, Sweden

[10] Salt Lake City Med Ctr, Dept Med Oncol, Kolkata, India

[11] Nuovo Osped Prato Ist Toscano Tumori, Dept Med Oncol, Prato, Italy

[12] Royal North Shore Hosp, Pam McLean Ctr, St Leonards, NSW, Australia

[13] Nova Med Sch, Lisbon, Portugal

[14] UNC Lineberger Comprehens Canc Ctr, Dept Hematol & Oncol, Chapel Hill, NC USA

[15] Quiron Grp, IOB Inst Oncol, Madrid, Spain

[16] Quiron Grp, IOB Inst Oncol, Barcelona, Spain

[17] Vall dHebron Inst Oncol, Dept Oncol, Barcelona, Spain

[18] Amer Univ Beirut, Dept Internal Med, Div Hematol Oncol, Med Ctr, Beirut, Lebanon

[19] European Breast Canc Coalit, Europa Donna, Milan, Italy

[20] Riviera Chablais Hosp, Interdisciplinary Oncol Serv SIC, Rennaz, Switzerland

[21] Univ Sussex, Brighton & Sussex Med Sch, SHORE C, Brighton, E Sussex, England

[22] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia

[23] BC Canc Agcy, Med Oncol Dept, Vancouver, BC, Canada

[24] Sorbonne Univ, AP HP, Breast Canc Expert Ctr, Univ Canc Inst, Paris, France

[25] Brustkrebs Deutschland eV, Munich, Germany

[26] Univ Munich LMU, Breast Ctr, Dept Obstet & Gynaecol, Munich, Germany

[27] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China

[28] Sheba Med Ctr, Dept Oncol, Ramat Gan, Israel

[29] Breast Canc Welf Assoc Malaysia, Petaling Jaya, Malaysia

[30] Sydney Med Sch, NHMRC Clin Trials Ctr, Sydney, NSW, Australia

[31] Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea

[32] Dana Farber Canc Inst, Susan Smith Ctr Womens Canc, Breast Oncol Ctr, Boston, MA 02115 USA

[33] Metastat Breast Canc Network, Inverness, IL USA

[34] Natl Inst Neoplast Dis, Dept Med Oncol, Lima, Peru

[35] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark

[36] Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan

[37] Geneva Univ Hosp, Med Sch, Geneva, Switzerland

[38] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[39] IDIBAPS, Translat Genom & Targeted Therapies Solid Tumors, Barcelona, Spain

[40] Univ Barcelona, Dept Med, Barcelona, Spain

[41] Ctr Jean Perrin, Dept Biopathol, Clermont Ferrand, France

[42] Univ Clermont Auvergne, INSERM U1240, Clermont Ferrand, France

[43] UCSF Helen Diller Family Comprehens Canc Ctr, Breast Oncol Clin Trials Educ, San Francisco, CA USA

[44] Stanford Sch Med, Div Oncol, Stanford, CA 94305 USA

[45] Martin Luther Univ Halle Wittenburg, Dept Gynaecol, Halle, Germany

[46] BelongLife, Oncol Res Unit, Tel Aviv, Israel

[47] Royal Marsden Hosp NHS Fdn Trust, Dept Appl Hlth Res Canc Care, London, England

[48] Chinese Acad Med Sci, Dept Med Oncol, Canc Hosp, Beijing, Peoples R China

[49] Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, 1275 York Ave, New York, NY 10021 USA

[50] European Sch Oncol, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷 / 12期

关键词：

ABC; advanced; breast cancer; ESO-ESMO; guidelines; metastatic; QUALITY-OF-LIFE; HORMONE REPLACEMENT THERAPY; MONARCH; ABEMACICLIB; PLUS FULVESTRANT; PHASE-III; POSTMENOPAUSAL WOMEN; MENOPAUSAL SYMPTOMS; VASOMOTOR SYMPTOMS; CONTROLLED-TRIAL; VAGINAL DRYNESS;

D O I：

10.1016/j.annonc.2020.09.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1623 / 1649

页数：27

共 141 条

[1]

ABC Global Alliance, 2018, ABC GLOB CHART 2018

[2] Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer [J].

Adam, J. ;

Le Stang, N. ;

Rouquette, I. ;

Cazes, A. ;

Badoual, C. ;

Pinot-Roussel, H. ;

Tixier, L. ;

Danel, C. ;

Damiola, F. ;

Damotte, D. ;

Penault-Llorca, F. ;

Lantuejoul, S. .

ANNALS OF ONCOLOGY, 2018, 29 (04) :953-958

[3] Liquid biopsy in breast cancer: A comprehensive review [J].

Alimirzaie, Sahar ;

Bagherzadeh, Maryam ;

Akbari, Mohammad R. .

CLINICAL GENETICS, 2019, 95 (06) :643-660

[4] Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update [J].

Allison, Kimberly H. ;

Hammond, M. Elizabeth H. ;

Dowsett, Mitchell ;

McKernin, Shannon E. ;

Carey, Lisa A. ;

Fitzgibbons, Patrick L. ;

Hayes, Daniel F. ;

Lakhani, Sunil R. ;

Chavez-MacGregor, Mariana ;

Perlmutter, Jane ;

Perou, Charles M. ;

Regan, Meredith M. ;

Rimm, David L. ;

Symmans, W. Fraser ;

Torlakovic, Emina E. ;

Varella, Leticia ;

Viale, Giuseppe ;

Weisberg, Tracey F. ;

McShane, Lisa M. ;

Wolff, Antonio C. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (12) :1346-+

[5] Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol [J].

Alves, Patricia ;

Amaral, Cristina ;

Teixeira, Natercia ;

Correia-da-Silva, Georgina .

PHARMACOLOGICAL RESEARCH, 2020, 157

[6] Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer [J].

Andre, Fabrice ;

Ciruelos, Eva ;

Rubovszky, Gabor ;

Campone, Mario ;

Loibl, Sibylle ;

Rugo, Hope S. ;

Iwata, Hiroji ;

Conte, Pierfranco ;

Mayer, Ingrid A. ;

Kaufman, Bella ;

Yamashita, Toshinari ;

Lu, Yen-Shen ;

Inoue, Kenichi ;

Takahashi, Masato ;

Papai, Zsuzsanna ;

Longin, Anne-Sophie ;

Mills, David ;

Wilke, Celine ;

Hirawat, Samit ;

Juric, Dejan .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) :1929-1940

[7]

[Anonymous], 2019, MED LETT DRUGS THER, V61, P179

[8]

[Anonymous], 2016, OBSTET GYNECOL, V127, pE93

[9]

[Anonymous], 2017, BREAST S1

[10]

[Anonymous], 2019, ANN ONCOL S5

← 1 2 3 4 5 6 7 8 9 10 →